My Application Form Status

Check the status of your application form with Angel Broking.
BPCL slips ex-dividend
Jun 06,2016

Meanwhile, the S&P BSE Sensex was down 19.93 points or 0.07% at 26,823.10

On BSE, so far 44,250 shares were traded in the counter as against average daily volume of 84,979 shares in the past one quarter. The stock hit high of Rs 1,010 and low of Rs 992.10 so far during the day. The stock had hit a record high of Rs 1,032 on 3 June 2016. The stock had hit a 52-week low of Rs 732.20 on 23 February 2016. The stock had underperformed the market over the past one month till 3 June 2016, rising 5.93% compared with Sensexs 6.39% rise. The scrip, however, outperformed the market in past one quarter, gaining 28.15% as against Sensexs 9.09% rise.

The large-cap company has equity capital of Rs 723.08 crore. Face value per share is Rs 10.

Before turning ex-dividend, the BPCL stock offered a dividend yield of 1.48% based on the stocks closing price of Rs 1,012.85 on the BSE on Friday, 3 June 2016.

Shares of BPCL are currently trading cum bonus. The company had recommended a 1:1 bonus issue on 26 May 2016. The stock will go ex-bonus on 13 July 2016. BPCL has fixed 14 July 2016 as the record date for the bonus issue.

BPCLs net profit fell 10.6% to Rs 2549.08 crore on 13.6% decline in total income to Rs 44891.65 crore in Q4 March 2016 over Q4 March 2015.

BPCL is a state-run oil refining-cum-marketing company. The Government of India currently holds 54.93% stake in BPCL (as per the shareholding pattern as on 31 March 2016).

Powered by Capital Market - Live News

Idea Cellular extends slide
Jun 06,2016

Meanwhile, the S&P BSE Sensex was down 90.98 points or 0.34% at 26,752.05.

On BSE, so far 9.86 lakh shares were traded in the counter as against average daily volume of 11.55 lakh shares in the past one quarter. The stock lost as much as 2.2% at the days low of Rs 104.20 so far during the day. The stock lost 0.14% at the days high of Rs 106.40 so far during the day. The stock had hit a 52-week low of Rs 97.55 on 10 February 2016. The stock had hit a 52-week high of Rs 186.50 on 22 July 2015. The stock had underperformed the market over the past one month till 3 June 2016, sliding 11.06% compared with Sensexs 6.39% rise. The scrip had also underperformed the market in past one quarter, declining 1.57% as against Sensexs 9.09% rise.

The large-cap company has equity capital of Rs 3600.63 crore. Face value per share is Rs 10.

Shares of Idea Cellular have tumbled 10.43% in two trading sessions from its close of Rs 118.35 on 2 June 2016 after US based private equity firm Providence Equity Partners through its arm P5 Asia Investments Mauritius Limited sold 12.50 crore shares of Idea Cellular at Rs 110.65 per share in a bulk deal on the NSE on Friday, 3 June 2016. Morgan Stanley Asia (Singapore) Pte bought 6.66 crore shares at Rs 110.41 per share. The stock had tumbled 9.97% to settle at Rs 106.55 on Friday, 3 June 2016.

As per the shareholding pattern of Idea Cellular as on 31 March 2016, Providence Equity Partners owned 6.81% stake in Idea Cellular through its arm P5 Asia Investments Mauritius Limited.

Idea Cellulars consolidated net profit fell 38.9% to Rs 575.63 crore on 12.7% growth in net sales to Rs 9462.57 crore in Q4 March 2016 over Q4 March 2015.

Idea Cellular is one of the leading telecom operators in India. It is a part of the Aditya Birla Group.

Powered by Capital Market - Live News

Idea Cellular extends losses
Jun 06,2016

Meanwhile, the S&P BSE Sensex was down 90.98 points or 0.34% at 26,752.05.

On BSE, so far 9.86 lakh shares were traded in the counter as against average daily volume of 11.55 lakh shares in the past one quarter. The stock lost as much as 2.2% at the days low of Rs 104.20 so far during the day. The stock lost 0.14% at the days high of Rs 106.40 so far during the day. The stock had hit a 52-week low of Rs 97.55 on 10 February 2016. The stock had hit a 52-week high of Rs 186.50 on 22 July 2015. The stock had underperformed the market over the past one month till 3 June 2016, sliding 11.06% compared with Sensexs 6.39% rise. The scrip had also underperformed the market in past one quarter, declining 1.57% as against Sensexs 9.09% rise.

The large-cap company has equity capital of Rs 3600.63 crore. Face value per share is Rs 10.

Shares of Idea Cellular have tumbled 10.43% in two trading sessions from its close of Rs 118.35 on 2 June 2016. The stock tumbled 9.97% in a single trading session to settle at Rs 106.55 on Friday, 3 June 2016, after US based private equity firm Providence Equity Partners through its arm P5 Asia Investments Mauritius Limited sold a large chunk of its holding in the company via a bulk deal on NSE. P5 Asia Investments Mauritius offloaded 12.50 crore shares of Idea Cellular at Rs 110.65 per share. Morgan Stanley Asia (Singapore) Pte bought 6.66 crore shares at Rs 110.41 per share in the same bulk deal.

As per the shareholding pattern of Idea Cellular as on 31 March 2016, P5 Asia Investments Mauritius Limited owned 24.50 crore shares constituting 6.81% stake in Idea Cellular.

Idea Cellulars consolidated net profit fell 38.9% to Rs 575.63 crore on 12.7% growth in net sales to Rs 9462.57 crore in Q4 March 2016 over Q4 March 2015.

Idea Cellular is one of the leading telecom operators in India. It is a part of the Aditya Birla Group.

Powered by Capital Market - Live News

Natco Pharma extends gains
Jun 06,2016

Meanwhile, the S&P BSE Sensex was down 16.20 points or 0.06% at 26,826.83.

On BSE, so far 45,000 shares were traded in the counter as against average daily volume of 65,424 shares in the past one quarter. The stock hit a high of Rs 530.60 and a low of Rs 505.10 so far during the day. The stock had hit a record high of Rs 623.60 on 5 January 2016. The stock had hit a 52-week low of Rs 382.20 on 24 August 2015. The stock had outperformed the market over the past one month till 3 June 2016, advancing 11.39% compared with Sensexs 6.39% rise. The scrip had, however, underperformed the market in past one quarter, gaining 8.15% as against Sensexs 9.09% rise.

The mid-cap company has equity capital of Rs 34.83 crore. Face value per share is Rs 2.

Shares of Natco Pharma have surged 9.72% in two trading sessions from its close of Rs 477.55 on 2 June 2016. The stock surged 8.54% to settle at Rs 518.35 during the previous trading session on Friday, 3 June 2016, on the back of the companys announcement that its marketing partner Mylan Inc. has received a tentative approval for its abbreviated new drug application (ANDA) for Sorafenib Tablets, 200mg from the United States Food and Drug Administration (USFDA). The drug is the generic version of NEXAVAR, which is indicated for the treatment of certain types of cancers including unresectable hepatocellular carcinoma and advanced renal cell carcinoma. Natco Pharma and Mylan have filed an ANDA containing a Paragraph IV certification for this product. Natco Pharma manufactures this product at its facility in Kothur, Telangana.

Bayer Healthcare LLC, Bayer Healthcare Pharmaceuticals Inc. and Onyx Pharmaceuticals Inc. sell Sorafenib Tablets, 200mg, under the brand name NEXAVAR in the US market. As per Bayers annual report, the NEXAVAR brand had sales of approximately $300 million in the US for the 12 months ending 31 December 2015.

Natco Pharmas consolidated net profit rose 10.7% to Rs 60.24 crore on 103% growth in net sales to Rs 386.77 crore in Q4 March 2016 over Q4 March 2015.

Natco Pharma manufactures generic dosage forms, bulk actives and intermediates for the Indian and international markets.

Powered by Capital Market - Live News

Natco Pharma extends Fridays rally
Jun 06,2016

Meanwhile, the S&P BSE Sensex was down 16.20 points or 0.06% at 26,826.83.

On BSE, so far 45,000 shares were traded in the counter as against average daily volume of 65,424 shares in the past one quarter. The stock hit a high of Rs 530.60 and a low of Rs 505.10 so far during the day. The stock had hit a record high of Rs 623.60 on 5 January 2016. The stock had hit a 52-week low of Rs 382.20 on 24 August 2015. The stock had outperformed the market over the past one month till 3 June 2016, advancing 11.39% compared with Sensexs 6.39% rise. The scrip had, however, underperformed the market in past one quarter, gaining 8.15% as against Sensexs 9.09% rise.

The mid-cap company has equity capital of Rs 34.83 crore. Face value per share is Rs 2.

Shares of Natco Pharma have surged 9.72% in two trading sessions from its close of Rs 477.55 on 2 June 2016, after the company during market hours on Friday, 3 June 2016 announced that its marketing partner, Mylan Inc. has received a tentative approval for its abbreviated new drug application (ANDA) for Sorafenib Tablets, 200mg, with the United States Food and Drug Administration (USFDA). The stock had surged 8.54% to settle at Rs 518.35 on Friday, 3 June 2016. This product is the generic version of NEXAVAR, which is indicated for the treatment of certain types of cancers including unresectable hepatocellular carcinoma and advanced renal cell carcinoma. Natco Pharma and Mylan have filed an ANDA containing a Paragraph IV certification for this product. Natco Pharma manufactures this product at its facility in Kothur, Telangana.

Bayer Healthcare LLC, Bayer Healthcare Pharmaceuticals Inc., and Onyx Pharmaceuticals Inc., sells Sorafenib Tablets, 200mg, under Brand name NEXAVAR, in the US market. For the 12 months ended 31 December 2015, NEXAVAR had US sales of approximately $300 million (as per Bayers annual report).

Natco Pharmas consolidated net profit rose 10.7% to Rs 60.24 crore on 103% growth in net sales to Rs 386.77 crore in Q4 March 2016 over Q4 March 2015.

Natco Pharma manufactures generic dosage forms, bulk actives and intermediates for the Indian and international markets.

Powered by Capital Market - Live News

Bharat Forge drops on buzz of a foreign brokerage retaining reduce rating on the stock
Jun 06,2016

Meanwhile, the S&P BSE Sensex was down 13.50 points or 0.05% at 26,829.53.

On BSE, so far 29,000 shares were traded in the counter as against average daily volume of 76,297 shares in the past one quarter. The stock was volatile. The stock lost as much as 1.88% at the days low of Rs 737 so far during the day. The stock rose as much as 0.31% at the days high of Rs 753.50 so far during the day. The stock had hit a 52-week low of Rs 705 on 24 May 2016. The stock had hit a 52-week high of Rs 1,292.50 on 20 August 2015. The stock had underperformed the market over the past one month till 3 June 2016, sliding 5.63% compared with Sensexs 6.39% rise. The scrip had also underperformed the market in past one quarter, declining 9.14% as against Sensexs 9.09% rise.

The large-cap company has equity capital of Rs 46.56 crore. Face value per share is Rs 2.

The target price of Rs 636 for the Bharat Forge stock set by the foreign brokerage is substantially lower than the ruling market price of Rs 744.45.

Bharat Forges net profit fell 19% to Rs 164.52 crore on 17.4% decline in net sales to Rs 987.07 crore in Q4 March 2016 over Q4 March 2015.

Bharat Forge is the flagship company of Kalyani Group. It is a global provider of high performance, innovative, safety & critical components and solutions to various industrial sectors including automotive, oil & gas, power, construction & mining, aerospace and rail & marine.

Powered by Capital Market - Live News

Bharat Forge drops on reports of weak order inflow in North America
Jun 06,2016

Meanwhile, the S&P BSE Sensex was down 13.50 points or 0.05% at 26,829.53.

On BSE, so far 29,000 shares were traded in the counter as against average daily volume of 76,297 shares in the past one quarter. The stock was volatile. The stock lost as much as 1.88% at the days low of Rs 737 so far during the day. The stock rose as much as 0.31% at the days high of Rs 753.50 so far during the day. The stock had hit a 52-week low of Rs 705 on 24 May 2016. The stock had hit a 52-week high of Rs 1,292.50 on 20 August 2015. The stock had underperformed the market over the past one month till 3 June 2016, sliding 5.63% compared with Sensexs 6.39% rise. The scrip had also underperformed the market in past one quarter, declining 9.14% as against Sensexs 9.09% rise.

The large-cap company has equity capital of Rs 46.56 crore. Face value per share is Rs 2.

According to reports, Bharat Forge derives around 20% of its standalone revenue from the North America heavy trucks segment.

Bharat Forges net profit fell 19% to Rs 164.52 crore on 17.4% decline in net sales to Rs 987.07 crore in Q4 March 2016 over Q4 March 2015.

Bharat Forge is the flagship company of Kalyani Group. It is a global provider of high performance, innovative, safety & critical components and solutions to various industrial sectors including automotive, oil & gas, power, construction & mining, aerospace and rail & marine.

Powered by Capital Market - Live News

Redington India drops after huge bulk deal
Jun 06,2016

Meanwhile, the BSE Sensex was down 31.75 points, or 0.12%, to 26,811.28

Bulk deal boosted volume on the scrip. On BSE, so far 2.76 crore shares were traded in the counter, compared with an average volume of 38,880 shares in the past one quarter. The stock hit a high of Rs 112.50 and a low of Rs 98.05 so far during the day. The stock hit a 52-week high of Rs 132 on 24 September 2015. The stock hit a 52-week low of Rs 91.20 on 19 June 2015. The stock had underperformed the market over the past one month till 3 June 2016, rising 4.36% compared with Sensexs 6.39% rise. The scrip had also underperformed the market in past one quarter, gaining 4.71% as against Sensexs 9.09% rise.

The mid-cap company has an equity capital of Rs 79.96 crore. Face value per share is Rs 2.

Redington Indias consolidated net profit rose 12.2% to Rs 137.56 crore on 27.7% rise in net sales to Rs 10474.32 crore in Q4 March 2016 over Q4 March 2015.

Redington India is a supply chain solutions provider worldwide to leading manufacturers of information technology, telecom, lifestyle and consumer electronics products.

Powered by Capital Market - Live News

M&M gains on favorable monsoon forecast
Jun 06,2016

Meanwhile, the S&P BSE Sensex was down 30.17 points or 0.11% at 26,812.86.

On BSE, so far 40,000 shares were traded in the counter as against average daily volume of 92,950 shares in the past one quarter. The stock hit a high of Rs 1,386.40 and a low of Rs 1,358 so far during the day. The stock had hit a record high of Rs 1,441.45 on 7 August 2015. The stock had hit a 52-week low of Rs 1,092 on 12 February 2016. The stock had underperformed the market over the past one month till 3 June 2016, advancing 2.08% compared with Sensexs 6.39% rise. The scrip had, however, outperformed the market in past one quarter, gaining 11.36% as against Sensexs 9.09% rise.

The large-cap company has equity capital of Rs 310.55 crore. Face value per share is Rs 5.

Shares of M&M had risen 1.55% to settle at Rs 1,353.45 during the previous trading session on Friday, 3 June 2016, after India Meteorological Department (IMD) retained its previous forecast of above normal rains for the 2016 southwest monsoon season (June to September). Good rains may boost demand for tractors. Mahindra & Mahindra (M&M) is the largest tractor maker in India in terms of market share.

Quantitatively, monsoon season rainfall for the country as a whole is likely to be 106% of the long period average (LPA) with a model error of plus/minus 4%, the IMD said after trading hours on 2 June 2016. In its first stage forecast issued on 12 April 2016, the IMD had forecast rainfall to be 106% of the LPA with a model error of plus/minus 5%.

IMD today, 6 June 2016, said that conditions continue to remain favorable for the onset of the southwest monsoon over Kerala during next 2-3 days. There has been delay in the onset of the monsoon rains in Kerala this year from the normal onset date which is 1 June. The arrival of the rains at the Kerala coast marks the onset of the June-September southwest monsoon season in India.

M&Ms net profit rose 6% to Rs 583.73 crore on 14.8% growth in net sales to Rs 10666.43 crore in Q4 March 2016 over Q4 March 2015.

The Mahindra Group enjoys a leadership position in tractors, utility vehicles, information technology, financial services and vacation ownership. In addition, Mahindra enjoys a strong presence in the agribusiness, aerospace, components, consulting services, defence, energy, industrial equipment, logistics, real estate, retail, steel, commercial vehicles and two-wheeler industries.

Powered by Capital Market - Live News

L&T gains as construction arm secures new orders worth Rs 2161 crore
Jun 06,2016

The announcement was made during market hours today, 6 June 2016.

Meanwhile, the BSE Sensex was down 10.34 points, or 0.04%, to 26,832.69

On BSE, so far 33,000 shares were traded in the counter, compared with an average volume of 2.17 lakh shares in the past one quarter. The stock hit a high of Rs 1,472.50 and a low of Rs 1,462.85 so far during the day. The stock hit a 52-week high of Rs 1,886.25 on 17 July 2015. The stock hit a 52-week low of Rs 1,016.60 on 12 February 2016. The stock had outperformed the market over the past one month till 3 June 2016, rising 16.8% compared with Sensexs 6.39% rise. The scrip had also outperformed the market in past one quarter, gaining 21.13% as against Sensexs 9.09% rise.

The large-cap company has an equity capital of Rs 186.37 crore. Face value per share is Rs 2.

In the transportation infrastructure business, L&Ts construction arm L&T Construction won a design a build order worth Rs 847 crore from Dedicated Freight Corridor Corporation of India (DFCCIL). In water and effluent treatment business, L&T Construction won engineering, procurement, and construction (EPC) orders worth Rs 709 crore. In power transmission and distribution business, L&T Construction won EPC orders worth Rs 403 crore. In metallurgical and material handling business, L&T Construction won additional orders worth Rs 202 crore from various ongoing jobs of this business, L&T said.

Meanwhile, Housing Development Finance Corporation (HDFC) after market hours on Friday, 3 June 2016 announced the acquisition of 100% stake in L&T General Insurance Company. HDFC said that the board of directors of HDFC ERGO General Insurance Company (HDFC ERGO), a non listed subsidiary of the company, has approved the acquisition of a 100% stake in L&T General Insurance Company (LTGI) for an aggregate consideration of Rs 551 crore. The board of HDFC ERGO also approved the plan to merge the two companies subject to all regulatory approvals. The acquisition would help HDFC ERGO improve its market position. HDFC ERGO expects significant cost synergies arising out of business, technology optimization and rationalization of offices. HDFC ERGO, a 51:49 joint venture between housing major HDFC and ERGO International, Germany (part of Munich Re Group), is the 4th largest private sector general insurer in India and offers all lines of general insurance products including motor, health, personal accident, home, fire, marine, aviation, liability, crop insurance etc. The transaction is subject to various approvals, including approval of Insurance Regulatory and Development Authority of India and the Bombay High Court. Upon closing, the L&T Group would exit from the general insurance and health insurance business. LTGI gross earned premium income during the year 2015-2016 was Rs 483 crore, constituting around 0.5% of the companys consolidated revenue for the year 2015-2016 and reported a net worth of Rs 142 crore as on 31 March 2016. The share sale is part of L&Ts strategy of exiting from its non-core activity.

L&Ts consolidated net profit rose 18.6% to Rs 2453.64 crore on 17.6% rise in total income to Rs 33423.78 crore in Q4 March 2016 over Q4 March 2015.

L&T is a major Indian multinational engaged in technology, engineering, construction, manufacturing and financial services, with global operations. Its products and systems are marketed in over 30 countries worldwide.

Powered by Capital Market - Live News

L&T gains on procuring new orders worth Rs 2161 crore
Jun 06,2016

The announcement was made during market hours today, 6 June 2016.

Meanwhile, the BSE Sensex was down 10.34 points, or 0.04%, to 26,832.69

On BSE, so far 33,000 shares were traded in the counter, compared with an average volume of 2.17 lakh shares in the past one quarter. The stock hit a high of Rs 1,472.50 and a low of Rs 1,462.85 so far during the day. The stock hit a 52-week high of Rs 1,886.25 on 17 July 2015. The stock hit a 52-week low of Rs 1,016.60 on 12 February 2016. The stock had outperformed the market over the past one month till 3 June 2016, rising 16.8% compared with Sensexs 6.39% rise. The scrip had also outperformed the market in past one quarter, gaining 21.13% as against Sensexs 9.09% rise.

The large-cap company has an equity capital of Rs 186.37 crore. Face value per share is Rs 2.

L&Ts transportation infrastructure business has won a design a build order worth Rs 847 crore from Dedicated Freight Corridor Corporation of India (DFCCIL). This order has been secured by the consortium of L&T and Instalaciones Inabensa, S.A., Spain.

In water and effluent treatment business, L&T has won EPC (engineering, procurement, and construction) orders worth Rs 709 crore. In power transmission and distribution business, L&T has won EPC orders worth Rs 403 crore. In metallurgical and material handling business, L&T has won additional orders worth Rs 202 crore from various ongoing jobs.

Meanwhile, L&T after market hours on Friday, 3 June 2016, announced that it has agreed to sell its entire stake in L&T General Insurance Company (LTGI) to HDFC ERGO General Insurance Company (HDFC ERGO) for an aggregate consideration of Rs 551 crore. L&T General Insurance Company is a wholly-owned subsidiary of L&T. The board of HDFC ERGO also approved the plan to merge the two companies subject to all regulatory approvals. The acquisition would help HDFC ERGO improve its market position. HDFC ERGO is a 51:49 joint venture between housing major HDFC and ERGO International, Germany (part of Munich Re Group). Once the transaction is completed, the L&T Group would exit the general insurance and health insurance businesses. LTGIs gross earned premium income during the year 2015-2016 totaled Rs 483 crore. It had net worth of Rs 142 crore as on 31 March 2016. The share sale is part of L&Ts strategy of exiting from its non-core activity.

L&Ts consolidated net profit rose 18.6% to Rs 2453.64 crore on 17.6% rise in total income to Rs 33423.78 crore in Q4 March 2016 over Q4 March 2015.

L&T is a major Indian multinational engaged in technology, engineering, construction, manufacturing and financial services. It operates in more than 30 countries worldwide.

Powered by Capital Market - Live News

Maruti declines on firmness in Japanese yen
Jun 06,2016

Meanwhile, the S&P BSE Sensex was up 4.11 points or 0.02% at 26,847.14.

On BSE, so far 4.92 lakh shares were traded in the counter as against average daily volume of 72,501 shares in the past one quarter. The stock hit a high of Rs 4,224.90 and a low of Rs 4,121 so far during the day. The stock had hit a record high of Rs 4,789 on 23 November 2015. The stock had hit a 52-week low of Rs 3,202.10 on 29 February 2016. The stock had outperformed the market over the past one month till 3 June 2016, advancing 10.56% compared with Sensexs 6.39% rise. The scrip had also outperformed the market in past one quarter, gaining 16.86% as against Sensexs 9.09% rise.

The large-cap company has equity capital of Rs 151.04 crore. Face value per share is Rs 5.

A strong yen adversely impacts Maruti Suzuki Indias (Maruti) operating profit margin. Maruti pays royalty to its Japanese parent Suzuki Motor Corporation in yen terms for some of its earlier models. Maruti has reportedly started paying royalty to its Japanese parent in rupee terms on all new models from 1 April 2016. Maruti also has an exposure to the yen to the extent it imports raw materials from Japan.

Maruti after market hours on Friday, 3 June 2016, reported 1.57% growth in its total production at 1.29 lakh units in May 2016 over May 2015. Marutis total sales rose 7.1% to 1.23 lakh units in May 2016 over May 2015.

Maruti Suzuki Indias net profit declined 11.7% to Rs 1133.60 crore on 12.5% growth in net sales to Rs 14929.50 crore in Q4 March 2016 over Q4 March 2015.

Maruti is Indias biggest car maker in terms of market share. Japanese parent Suzuki Motor Corporation held 56.21% stake in Maruti (as per the shareholding pattern as on 31 March 2016).

Powered by Capital Market - Live News

Indiabulls Real Estate gains after entering into development pact with Oricon
Jun 06,2016

The announcement was made after market hours on Friday, 3 June 2016.

Meanwhile, the S&P BSE Sensex was up 17.91 points or 0.07% at 26,860.94.

On BSE, so far 4.73 lakh shares were traded in the counter as against average daily volume of 18.81 lakh shares in the past one quarter. The stock hit a high of Rs 100.20 and a low of Rs 96.65 so far during the day. The stock had hit a 52-week high of Rs 105.25 on 30 May 2016. The stock had hit a 52-week low of Rs 41 on 18 June 2015. The stock had outperformed the market over the past one month till 3 June 2016, advancing 39.07% compared with Sensexs 6.39% rise. The scrip had also outperformed the market in past one quarter, gaining 89.27% as against Sensexs 9.09% rise.

The mid-cap company has equity capital of Rs 101.13 crore. Face value per share is Rs 2.

Indiabulls Real Estate said that its 100% subsidiary, Tapir Realty Developers, has entered into a joint development agreement with Oricon Properties, a subsidiary of Oricon Enterprises, for development of 7,810 square meters plot situated at Worli in Mumbai.

On consolidated basis, Indiabulls Real Estates net profit fell 36.7% to Rs 58.91 crore on 4.5% growth in net sales to Rs 617.69 crore in Q4 March 2016 over Q4 March 2015.

Indiabulls Real Estate is one of the largest real estate company in India with development projects spread across high-end office and commercial complexes, premium residential developments, mega townships, retail spaces, hotel and resorts, state of the art special economic zones and infrastructure development.

Powered by Capital Market - Live News

Indiabulls Real Estate gains after entering into a pact for development of a plot in Mumbai
Jun 06,2016

Shares of Oricon Enterprises were down 1.37% at Rs 64.60. The announcement was made after market hours on Friday, 3 June 2016.

Meanwhile, the S&P BSE Sensex was up 17.91 points or 0.07% at 26,860.94.

On BSE, so far 4.73 lakh shares were traded in the Indiabulls Real Estate counter as against average daily volume of 18.81 lakh shares in the past one quarter. The stock hit a high of Rs 100.20 and a low of Rs 96.65 so far during the day. The stock had hit a 52-week high of Rs 105.25 on 30 May 2016. The stock had hit a 52-week low of Rs 41 on 18 June 2015. The stock had outperformed the market over the past one month till 3 June 2016, advancing 39.07% compared with Sensexs 6.39% rise. The scrip had also outperformed the market in past one quarter, gaining 89.27% as against Sensexs 9.09% rise.

The mid-cap company has equity capital of Rs 101.13 crore. Face value per share is Rs 2.

Oricon Properties is a wholly-owned subsidiary of Oricon Enterprises.

On consolidated basis, Indiabulls Real Estates net profit fell 36.7% to Rs 58.91 crore on 4.5% growth in net sales to Rs 617.69 crore in Q4 March 2016 over Q4 March 2015.

Indiabulls Real Estate is one of the largest real estate development companies in India with development projects spread across high-end office and commercial complexes, premium residential developments, mega townships, retail spaces, hotel and resorts, special economic zones and infrastructure development.

Powered by Capital Market - Live News

Jubilant Life Sciences advances after getting ANDA approval for Levetiracetam
Jun 06,2016

The announcement was made after market hours on Friday, 3 June 2016.

Meanwhile, the S&P BSE Sensex was down 5.69 points or 0.02% at 26,837.34

On BSE, so far 53,360 shares were traded in the counter as against average daily volume of 1.53 lakh shares in the past one quarter. The stock hit a high of Rs 374 and a low of Rs 366.25 so far during the day. The stock had hit a record high of Rs 455 on 7 December 2015. The stock had hit a 52-week low of Rs 163.35 on 29 June 2015. The stock had underperformed the market over the past one month till 3 June 2016, falling 9.42% compared with Sensexs 6.39% rise. The scrip had also underperformed the market in past one quarter, declining 4.71% as against Sensexs 9.09% rise.

The mid-cap company has equity capital of Rs 15.93 crore. Face value per share is Re 1.

Jubilant Life Sciences announced that the company has received Abbreviated New Drug Application (ANDA) final approval for Levetiracetam Injection USP, 500 mg/5 mL (100 mg/mL), the generic version of Keppra Injection 500mg/5mL (100mg/mL) of UCB, which is used for the treatment of epilepsy. As on 31 March 2016, Jubilant Life Sciences had a total of 739 filings for formulations of which 517 have been approved in various regions globally. This includes 72 ANDAs filed in the US, of which 44 have been approved and 46 Dossier filings in Europe.

Jubilant Life Sciences consolidated net profit rose 65.4% to Rs 70.68 crore on 2.8% fall in net sales to Rs 1480.29 crore in Q4 March 2016 over Q4 March 2015.

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in manufacture and supply of APIs, solid dosage formulations, specialty pharmaceuticals and life science ingredients. It also provides services in contract manufacturing and drug discovery solutions.

Powered by Capital Market - Live News